Back to Archived Journals » Comparative Effectiveness Research » Volume 8

Corrigendum

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]

       
Total article views   HTML views PDF downloads Totals
5,538 Dovepress* 5,538+ 663 6,201
Totals 5,538 663 6,201
*Since 24 January 2018

View citations on Google Scholar